Literature DB >> 109343

Detection of HBe antigen in sera from HBs antigen asymptomatic carrier and hepatitis patients using polyethylene glycol (PEG).

T Tsuji, T Okada, H Nagashima.   

Abstract

Serum and plasma samples concentrated 8 to 10 times with polyethylene glycol (PEG) having a molecular weight of 6,000 were examined by micro-Ouchterlony (MO) analysis with a view to increasing the detection sensitivity for HBe antigen (HBeAg), one of the hepatitis B virus associated antigens, and HBe antibody (HBeAb). The subjects of this investigation consisted of 82 symptom-free HBsAg carriers and 59 patients with B hepatitis. HBeAg was detected in 22 (26.8%) and HBeAb in 43 (52.4%) of 82 asymptomatic HBsAg carriers, and 17 (20.7%) were negative for both HBeAg and HBeAb. The corresponding values for the liver disease patients were 7 (11.9%), 16 (22.1%) and 36 (61.0%). Histologically, the rate of detection for HBeAg was higher in the cases of a mild disturbance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109343     DOI: 10.1007/bf02774068

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  16 in total

1.  Tissue localization of C1q in HBs antigen positive liver disease patients by direct immunofluorescent technique.

Authors:  T Tsuji; K Naito; K Araki; K Onoue; H Nozaki; H Nagashima
Journal:  Acta Med Okayama       Date:  1977-02       Impact factor: 0.892

2.  Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme.

Authors:  J O Nielsen; O Dietrichson; E Juhl
Journal:  Lancet       Date:  1974-10-19       Impact factor: 79.321

3.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

4.  Letter: Decreasing frequency of e antigen with age in serum of symptom-free carriers of hepatitis B antigen.

Authors:  A Ohbayashi; Y Matsuo; T Mozai; M Imai; M Mayumi
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321

5.  Acute and chronic hepatitis revisited. Review by an international group.

Authors: 
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

6.  Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.

Authors:  N Eleftheriou; H C Thomas; J Heathcote; S Sherlock
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

7.  Behaviour of e antigen and antibody during chronic active liver disease. Relation to HB antigen-antibody system and prognosis.

Authors:  A J Vogten; W H Summerskill; G L Gitnick; S W Schalm; J L Smith; B L Murphy; J E Maynard
Journal:  Lancet       Date:  1976-07-17       Impact factor: 79.321

8.  Characterization of a new antigen-antibody system associated with hepatitis B.

Authors:  L O Magnius
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

9.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

10.  Detection of liver HBc antigen and its antibody in sera from viral hepatitis by the immunofluorescent complement technique.

Authors:  T Tsuji; K Tokuyama; T Okada; S Takata; K Naito
Journal:  Acta Med Okayama       Date:  1976-02       Impact factor: 0.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.